Citation

BibTex format

@article{Vieira:2026:10.1016/j.jaip.2026.05.035,
author = {Vieira, RJ and di, Bona D and Bognanni, A and Martini, M and Ordak, M and Paoletti, G and Canonica, GW and Giovannini, M and Haahtela, T and Larenas-Linnemann, DE and Nogueira-Leite, D and Pfaar, O and Williams, S and Pereira, AM and Klimek, L and Shamji, MH and Torres, MJ and Fonseca, JA and Zuberbier, T and Bousquet, J and Sousa-Pinto, B},
doi = {10.1016/j.jaip.2026.05.035},
journal = {J Allergy Clin Immunol Pract},
pages = {2143--2154.e6},
title = {Estimating Work-Related Indirect Costs in Allergic Rhinitis and Asthma Using a Daily Combined Symptom-Medication Score: A MASK-air Study in Collaboration With the EAACI Methodology Committee.},
url = {http://dx.doi.org/10.1016/j.jaip.2026.05.035},
volume = {14},
year = {2026}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - BACKGROUND: Allergic rhinitis and asthma can impair work productivity. OBJECTIVE: To validate a daily work productivity visual analogue scale (VAS work), comparing it with the Work Productivity and Activity Impairment questionnaire plus Classroom Impairment Questions: Allergy Specific (WPAI+CIQ:AS) and also to quantify how allergy control relates to work impairment and indirect costs. METHODS: We conducted a cross-sectional study using data from the MASK-air app. Patients recorded daily VAS and weekly WPAI+CIQ:AS responses. We calculated correlations between VAS work and WPAI+CIQ:AS outcomes. Mixed-effects regression models assessed associations between disease control, measured by the Combined Symptom-Medication Score (CSMS) and the electronic daily asthma control score (e-DASTHMA), and VAS work. Indirect costs were estimated using the human capital approach, applying VAS-based productivity losses to country-specific wage distributions. RESULTS: VAS work correlated strongly with the WPAI+CIQ:AS, with Spearman coefficients 0.70 or higher for total work impairment and presenteeism. Each 1-point increase in CSMS and e-DASTHMA was associated with mean 0.97- and 0.79-point increases in VAS work, respectively. On poorly controlled days, the estimated daily indirect cost based on CSMS ranged from US $12.50 purchasing power parities (PPP) (P25-P75, 5.60-26.70) in Brazil to US $129.90 PPP (P25-P75, 80.40-199.40) in Iceland. Based on e-DASTHMA, daily estimates ranged from US $9.30 PPP (P25-P75, 3.70-21.50) in Brazil to US $101.90 PPP (P25-P75, 51.20-172.40) in Iceland. CONCLUSIONS: VAS work is a valid simple daily measure of work impairment due to rhinitis and asthma. CSMS and e-DASTHMA can be used to estimate productivity losses attributable to poor disease control.
AU  - Vieira,RJ
AU  - di,Bona D
AU  - Bognanni,A
AU  - Martini,M
AU  - Ordak,M
AU  - Paoletti,G
AU  - Canonica,GW
AU  - Giovannini,M
AU  - Haahtela,T
AU  - Larenas-Linnemann,DE
AU  - Nogueira-Leite,D
AU  - Pfaar,O
AU  - Williams,S
AU  - Pereira,AM
AU  - Klimek,L
AU  - Shamji,MH
AU  - Torres,MJ
AU  - Fonseca,JA
AU  - Zuberbier,T
AU  - Bousquet,J
AU  - Sousa-Pinto,B
DO  - 10.1016/j.jaip.2026.05.035
EP  - 2154
PY  - 2026///
SP  - 2143
TI  - Estimating Work-Related Indirect Costs in Allergic Rhinitis and Asthma Using a Daily Combined Symptom-Medication Score: A MASK-air Study in Collaboration With the EAACI Methodology Committee.
T2  - J Allergy Clin Immunol Pract
UR  - http://dx.doi.org/10.1016/j.jaip.2026.05.035
UR  - https://www.ncbi.nlm.nih.gov/pubmed/42276378
VL  - 14
ER  -
Download